Clinical Trials · NCT02161588
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 48
- Start date
- Jun 2014
- Locations
- 1 site, Japan
- Primary endpoint
- Area under the semaglutide plasma concentration-time curve